JESSICA GONZALEZ: Open Payments
NPI 1508547373 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,880 in 65 payments from 17 companies in 2025. Trend: 2023 $52 · 2024 $1,235 · 2025 $1,880
Food & beverage: $1,880
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $651 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $215 |
| Madrigal Pharmaceuticals | 3 | $197 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $162 |
| Novo Nordisk Inc | 1 | $125 |
| Ardelyx, Inc. | 4 | $96 |
| Janssen Biotech, Inc. | 4 | $84 |
| GENZYME CORPORATION | 3 | $82 |
| Teleflex LLC | 1 | $76 |
| Lilly USA, LLC | 2 | $52 |
Products named: SKYRIZI, REZDIFFRA, CREON, XIFAXAN, RINVOQ, ENTYVIO, Wegovy, IBSRELA.
Industry payments across FL — which companies pay providers there.
